Piramal Pharma to invest ₹1,000 cr for expansion: Nandini Piramal
After a challenging previous year, Piramal Pharma is focusing on growth and cost control for recovery and turnaround
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.